Literature DB >> 30156102

Asbestos: Modern Insights for Toxicology in the Era of Engineered Nanomaterials.

Emanuela Felley-Bosco1, Marion MacFarlane2.   

Abstract

Asbestos fibers are naturally occurring silicates that have been extensively used in the past, including house construction, but because of their toxicity, their use has been banned in 63 countries. Despite this, more than one million metric tons of asbestos are still consumed annually in countries where asbestos use has not been banned. Asbestos-related disease incidence is still increasing in several countries, including those countries that banned the use of asbestos more than 30 years ago. We highlight here recent knowledge obtained in experimental models about the mechanisms leading to tumor development following asbestos exposure, including genetic and epigenetic changes. Importantly, the landscape of alterations observed experimentally in tumor samples is consistent with alterations observed in clinical tumor samples; therefore, studies performed on early/precancer stages should help inform secondary prevention, which remains crucial in the absence of an efficient primary prevention. Knowledge gathered on asbestos should also help address future challenges, especially in view of the increased production of new materials that may behave similarly to asbestos fibers.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30156102     DOI: 10.1021/acs.chemrestox.8b00146

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  8 in total

1.  Analysis of Nanomaterials on Biological and Environmental Systems and New Analytical Methods for Improved Detection.

Authors:  Sarah Reagen; Julia Xiaojun Zhao
Journal:  Int J Mol Sci       Date:  2022-06-06       Impact factor: 6.208

Review 2.  Metabolic rewiring and redox alterations in malignant pleural mesothelioma.

Authors:  Loredana Urso; Ilaria Cavallari; Evgeniya Sharova; Francesco Ciccarese; Giulia Pasello; Vincenzo Ciminale
Journal:  Br J Cancer       Date:  2019-12-10       Impact factor: 7.640

3.  Hand2 delineates mesothelium progenitors and is reactivated in mesothelioma.

Authors:  Karin D Prummel; Helena L Crowell; Susan Nieuwenhuize; Eline C Brombacher; Stephan Daetwyler; Charlotte Soneson; Jelena Kresoja-Rakic; Agnese Kocere; Manuel Ronner; Alexander Ernst; Zahra Labbaf; David E Clouthier; Anthony B Firulli; Héctor Sánchez-Iranzo; Sundar R Naganathan; Rebecca O'Rourke; Erez Raz; Nadia Mercader; Alexa Burger; Emanuela Felley-Bosco; Jan Huisken; Mark D Robinson; Christian Mosimann
Journal:  Nat Commun       Date:  2022-03-30       Impact factor: 14.919

4.  Assessing size-dependent cytotoxicity of boron nitride nanotubes using a novel cardiomyocyte AFM assay.

Authors:  Jerry Augustine; Timothy Cheung; Valerie Gies; Jennifer Boughton; Maohui Chen; Zygmunt J Jakubek; Steven Walker; Yadienka Martinez-Rubi; Benoit Simard; Shan Zou
Journal:  Nanoscale Adv       Date:  2019-03-26

5.  Hedgehog Signaling in Mesothelioma: 2019 Status.

Authors:  Emanuela Felley-Bosco
Journal:  Front Genet       Date:  2019-11-07       Impact factor: 4.599

Review 6.  RNA editing in mesothelioma: a look forward.

Authors:  Ananya Hariharan; Suna Sun; Martin Wipplinger; Emanuela Felley-Bosco
Journal:  Open Biol       Date:  2020-10-14       Impact factor: 6.411

7.  Double-Stranded RNA Structural Elements Holding the Key to Translational Regulation in Cancer: The Case of Editing in RNA-Binding Motif Protein 8A.

Authors:  Asra Abukar; Martin Wipplinger; Ananya Hariharan; Suna Sun; Manuel Ronner; Marika Sculco; Agata Okonska; Jelena Kresoja-Rakic; Hubert Rehrauer; Weihong Qi; Victor W van Beusechem; Emanuela Felley-Bosco
Journal:  Cells       Date:  2021-12-15       Impact factor: 6.600

8.  Prostate Cancer and Asbestos: A Systematic Review and Meta-Analysis.

Authors:  Frédéric Dutheil; Laetitia Zaragoza-Civale; Bruno Pereira; Martial Mermillod; Julien S Baker; Jeannot Schmidt; Fares Moustafa; Valentin Navel
Journal:  Perm J       Date:  2020-02-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.